MedTrace Logo

Behavioral and Pharmacological Treatment for Insomnia

NCT00042146 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2013-05-21

No results posted yet for this study

Summary

This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (Ambien®), for chronic insomnia.

Conditions

  • Sleep Initiation and Maintenance Disorders

Interventions

BEHAVIORAL

Cognitive-behavior therapy

DRUG

zolpidem

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Laval University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00042146 on ClinicalTrials.gov